Computational prediction of bioactivity has become a critical aspect of modern drug discovery as it mitigates the cost, time, and resources required to find and screen new compounds. Deep Neural Networks (DNN) have recently shown excellent performance in modeling Protein-Ligand Interaction (PLI). However, DNNs are only effective when physically sound descriptions of ligands and proteins are fed into the neural network for processing. Furthermore, previous research has not incorporated the secondary structure of proteins in a meaningful manner. In this work, we developed a DNN framework that utilizes the secondary structure information of proteins which is extracted as the curvature and torsion of the protein backbone to predict PLI. We demonstrate how our model outperforms previous machine and non-machine learning models on four major datasets: humans, C.elegans, DUD-E, and BindingDB. Visualization of the intermediate layers of our model shows a potential latent space for proteins which extracts important information about the bioactivity. We further investigate the inner workings of our model by visualizing the most important aspects in a protein that the model finds influential. We observed that our model learns important information about possible locations where a ligand would bind including binding sites, allosteric sites and cryptic sites, regardless of the conformation used. This work opens the door to the exploration of secondary structure based deep learning in general, which is not just confined to protein-ligand interactions.
Introduction
The interaction between proteins and small molecules is a complex mechanism which biological systems adopt to regulate many fundamental operations. These interactions are governed by a multitude of factors including hydrogen bonding 1,2 , π-interactions 3 , hydrophobicity 4 etc. The experimental validation of Protein-Ligand Interaction (PLI) is the state-of-theart method, however, it is time-consuming and expensive. Computational methods can significantly boost time and save resources, however, due to the complex nature of PLI its prediction is a challenging computational enterprise. However, reliable PLI predictions could significantly reduce the discovery time for new treatments, eliminate toxic drug candidates and efficiently guide medicinal chemistry efforts 5 . It is therefore imperative to develop computational methods to predict PLI despite the complexity of the problem.
Traditional PLI relies on high-throughput screening which is an experimental technique with high cost and low efficiency 6 . Virtual screening (VS) accelerates the PLI process while greatly reducing time and resources. Broadly, VS can be divided in two major categories:
Ligand Based Virtual Screening (LBVS) and Structure Based Virtual Screening (SBVS) 7 .
LBVS applies known sets of ligands to a target of interest and therefore, its capability to find novel chemotypes is limited. SBVS uses the 3D structure of a given target and therefore is a better choice for the discovery of novel active compounds 8 . However, SBVS has a somewhat poor performance, sometimes not being able to distinguish active from inactive compounds 9 . Over the last few decades, many classical techniques such as force field, empirical and knowledge based 5 PLI predictions have been applied, however, often showing low performance and in some cases even discrepancies when compared with experimental bioactivities 10 .
Machine learning (ML) and Deep learning (DL) approaches have recently received attention in this field. Various reviews summarize the application of ML/DL in drug design and discovery [11] [12] [13] [14] [15] . Machine learning based PLI prediction has been developed from a chemogenomics perspective 16 that considers interactions in a unified framework from chemical space and genomic space. Jacob and Vert 17 used tensor-product based features and applied Support Vector Machines (SVM) to predict PLI. Yamanishi et al. 18 minimized Euclidean distances over common features derived by mapping ligands and proteins. Wallach et al. 19 used a 3D grid for proteins along with 3D convolutional networks. Tsubaki et al. 20 used a combination of convolutional network for proteins and graph network for ligands. Li et al. 21 used Bayesian additive regression trees to predict PLI. Lee et al. 22 applied deep learning with convolution on protein sequences.
Most of the protein structure based models (ML/DL) for PLI predictions achieve low accuracy as i) high resolution protein-ligand pair for training is mostly absent, ii) the 3D grid for the target is large and sparse matrix, which hinder ML/DL models to learn and predict PLI. In this work, we propose a secondary structure based representation for proteins with a 1D vector contrary to 3D 19 or 2D 23 based representations. The 1D representation is based on the curvature and torsion of protein backbone and therefore does not necessarily require high resolution geometry information. Mathematically, curvature and torsion are sufficient to reasonably represent the 3D structure of a protein 24 and therefore contains compact information about it's function.
Tremendous work has been carried out to represent the ligands. Gómez-Bombarelli et al. 25 created a model to generate Continuous Latent Space (CLP) from sparse Simplified Molecular-Input Line-Entry System (SMILES) strings (i.e., a string representation of a molecule) based on a variational autoencoder similar to word embedding 26 . Scarselli et al. 27 proposed a Graph Neural Network (GNN) to describe molecules. Rogers and Hahn 28 developed Extended-Connectivity Fingerprints (ECF), which includes the presence of substructures (and therefore also includes stereochemical information) to represent molecules.
Riniker and Landrum 29 proposed a fingerprint based on substructure and their similarity (Avalon).
End-to-end learning, a powerful ML/DL technique to exploit drug discovery and development, has gained interest in recent years 30 . The end-to-end learning technique involves i) embedding inputs to lower dimensions, ii) formulating various neural networks depending on the data available, and iii) using backpropagation over the whole architecture to minimize loss and update weights. In this work, we utilize such an architecture where the proteins and the ligands are transformed into lower dimensions with the help of convolutional and fully connected dense networks. We coin this neural network based end-to-end learning model SSnet. A general overview of the SSnet model is shown as Figure 2 of the supporting information.
The goal of this work is to predict binary PLI (1 is active, 0 is inactive). Any other analysis carried out is to show the robustness and versatility of the model. This limits the scope of this research to perform indepth analysis on various demeanor that can be carried out utilizing secondary structure information such as locating binding site, prediction of selectivity among ligands, pose prediction etc.
We analyzed the SSnet model by utilizing the Grad-CAM method 31 . Grad-CAM is a useful technique to visualize heatmaps of the activation from networks that maximally excite the input feature. In other words, it shows the important data points in the input feature that are responsible for the prediction. We show that our model learns the important residues in the protein which the machine finds most important for PLI prediction. With the heatmap information we tend to answer why curvature and torsion is an important tool for representation of proteins for ML/DL models. This analysis also proves that SSnet is not learning irrelevant information and therefore can generalize for unknown proteins and ligands.
Often in virtual screening, only few conformations for an unknown protein are available that requires immediate attention (eg. in epidemics such as SARS-CoV-2 32 , Marburg Virus 33 etc.). We tested several conformations of a protein and observed that SSnet can predict similar results from apo protein (protein without ligand) or from a different conformation of the protein (protein with a different ligand). We further observed that SSnet can also predict PLI for cryptic proteins (proteins that undergo a significant conformational change upon ligand binding which results in the opening of cryptic binding sites). SSnet thus shows a versatile nature in predicting PLI and therefore is not confined to require a unique conformation of protein-ligand complex.
In the following we first demonstrate how the secondary structure of proteins can be used in ML/DL. Then we discuss the representation of ligands following the introduction of SSnet model, possible evaluation criteria, its merits and demerits. Then we explain the datasets used in this work and analyze the performance and outcomes of SSnet in the Results and Discussion section. We then unbox the SSnet model by visualizing heatmaps of the proteins.
Finally, we summarize and conclude our work and provide a future perspective.
Representation of Proteins
Protein structures exhibit a large conformational variety which has traditionally been modeled through complex combinations of primary, secondary, tertiary, and quaternary levels.
Many automated and manual sorting databases like SCOP 34 , CATH 35 , DALI 36 , and programs like DSSP 37 STRIDE 38 , DEFINE 39 , and KAKSI 40 etc. have provided protein classifications based on the secondary structure. However, these classifications are often conflict- Figure 1 : a) The tangent vector t, normal vector n and the binormal vector b of a Frenet frame at points P 1 and P 2 respectively for a curve r(s). b) Representation of protein backbone in terms of scalar curvature κ and torsion τ respectively. The ideal helix, turn and non-ideal helix is shown in orange, cyan and magenta respectively. The curvature and torsion pattern captures the secondary structure of the protein.
ing 41 . A more promising approach to determine protein fold based on secondary structure has been introduced by Ranganathan et al. 24 where a reaction path is characterized by arc length, curvature, and torsion. Inspired by the representation of features in APSA, we tend to answer what, if, and how can we utilize the secondary structure in ML/DL approaches for Protein Ligand Interaction (PLI) prediction.
In this approach a protein is represented by the α carbons (CA atoms) of the backbone as it defines a unique and recognizable structure, especially for protein categorization 44 . In fact, a significant amount of information about the protein is embedded in the secondary structure elements such as helices, β sheets, hairpins, coils, and turns etc. Therefore, it is imperative to incorporate the secondary structure of the protein when representing its features for machine learning approaches. Otherwise, the algorithms will be blind to interactions dependent on the secondary structure.
The secondary structure information can be retrieved by a smooth curve generated by a cubic spline fit of the CA atoms. Figure 1a shows the arc length s, scalar curvature κ and scalar torsion τ which define the 3D curve r(s). The scalar curvature κ is expressed as a function of arc length s κ(s) = |r (s)| (1) and the scalar torsion
where | · | is the norm and · is the vector triple product. A protein can then be represented by considering the curvature and torsion at the anchor points (locations of CA) forming a 1D vector with twice the the number of amino acids. machine learning techniques may be powerful tools to predict PLI through efficiently learned representations of these patterns. More specifically, we hypothesized that, using convolution, varying sized filters may be excellent pattern matching methods for discerning structure from these decomposition plots. More analysis on protein representation is provided in the section SSnet.
Representation of Ligands
A molecule can be represented by the SMILES string, which represents its various bonds and orientations. However, the SMILES string is sparse and does not necessarily provide information about the ligand structure in an efficient way. Therefore, SMILES strings are difficult for machine learning algorithms to effectively learn from. A number of alternative representations for ligands have been proposed that model varying aspects of the ligand in a more machine readable format. The hope has been that machine learning algorithms can more effectively use these representations for prediction. Since ligand representation is an ongoing research topic, we consider four different methods: CLP 25 , GNN 27 , Avalon 29 , and ECF 28 . CLP was generated by the code provided by Gómez-Bombarelli et al. 25 ; Avalon and ECF were generated from RDKit 45 ; and GNN was implemented as proposed by Tsubaki et al. 20 . Figure 2 shows the SSnet model developed in this work. We provide here a general overview of the network and more details about its specific design operation is given in the later part of this section. As denoted in the left upper branch of Figure 2 after conversion into the Frenet-Serret frame and the calculation of curvature κ and torsion τ , κ and τ data (i.e decomposition data) is fed into the neural network. We denote this input as a 2D matrix (1D vector with curvature and torsion reshaped to contain curvature in one row and torsion in the other), X (0) , where each column represents a unique residue and the rows corresponding the curvature and torsion. The first layer is a branch convolution with varying window sizes. That is, each branch is a convolution with a filter of differing length. We perform this operation so that patterns of varying lengths in the decomposition plot can be recognized by the neural network. Each branch is then fed to more convolutions of same window size.
SSnet model
This allows the network to recognize more intricate patterns in X (0) that might be more difficult to recognize with a single convolution. The output of these convolutional branches are concatenated, pooled over the length of the sequence, and fed to a fully connected dense layer. The rightmost upper branch of Figure 2 shows a ligand vector which is generated and fed to a fully connected dense layer. The output of this layer is typically referred to as an embedding. Intuitively, this embedding is a reduced dimensionality representation of the Protein concatenate layer Figure 2 : SSnet model. The curvature and torsion pattern of a protein backbone is fed through multiple convolution networks with varying window sizes as branch convolution. Each branch further goes through more convolution with same window size (red, orange, green and light blue boxes). A global max pooling layer is implemented to get the protein vector. The ligand vector is directly fed to the network. Each double array line implies a fully connected dense layer. The number inside a box represents the dimension of the corresponding vector. In the case of GNN, the ligand vector is replaced by a graph neural network as implemented by Tsubaki et al. 20 protein and ligand. The outputs of the protein embedding and the ligand embedding are then concatenated and fed to further dense layers to predict the PLI.
The convolutional network in this research uses filter functions over the protein vector X (0) . To define the convolution operation more intuitively, we define a reshaping operation as follows:
where the flattening operation reshapes the row of X (0) from indices i to i+K to be a column vector c
i . This process is also referred to as vectorization. The size of the filter will then be of length K. We define the convolution operation as:
where f is a function known as the rectified linear unit (ReLU), W (0) conv is the weight matrix and b (0) conv is the bias vector. This operation fills in the columns of the output of the convolution, X (1) row=i,∀col (also called the activation or feature map). Each row of W (0) conv is considered as a different filter and each row of X (1) is the convolutional output of each of these filters.
These convolutions can be repeated such that the n th activation is computed as:
We in our SSnet model use four different branches with filter sizes of κ = 5, 10, 15 and 30.
The final convolutional activations for layer N can be referred to as X (N ) κ where κ denotes the branch. The activation X (N ) κ is often referred to as the latent space because it denotes the latent features of the input sequence. The number of columns in X (N ) κ is dependent upon the size of the input sequence. To collapse this unknown size matrix into a fixed size vector, we apply a maximum operation along the rows of X (N ) κ . This is typically referred to as a Global Max Pooling layer in neural networks and is repeated R times for each row in X (N ) κ :
where d κ is a length R column vector regardless of the number of columns in the latent space X (N ) κ . This maximum operation, while important, has the effect of eliminating much of the information in the latent space. To better understand the latent space, we can further process X (N ) κ to understand how samples are distributed. For example, a simple operation would be to define another column vector v that denotes the total variation in each row of the latent space:
The concatenation of vectors d and v help elucidate how the samples are distributed in the latent space. As such, we can use these concatenated vectors as inputs to a fully connected dense layer which can learn to interpret the latent space. This output is referred to as the embedding of the protein, y prot , and is computed as
where W prot is the learned weight matrix and b prot is the bias vector of a fully connected network.
The method described above is similar to a technique recently used in speech verification systems where the window sizes need to be dynamic because the length of audio snippet is unknown. In speech systems, the latent space is collapsed via mean and standard de-viation operations and the embeddings provided for these operations are typically referred to as D-Vectors 46 or X-Vectors 47 . In proteins we have a similar problem as the length of the decomposition sequence to consider the active site(s) of protein is dynamic and are of unknown sizes. By including the window sizes of 5, 10, 15 and 20 (number of residues to consider at a time), we ensure that the network is able to extract different sized patterns from backbones of varying length.
After embedding the protein and the ligand, we concatenate the vectors together and feed them into the final neural network branch, resulting in a prediction of binding,ŷ, which is expected to be closer to "0" for ligands and proteins that do not bind and closer to "1" for proteins and ligands that do bind. This final branch consists of two layers:
where σ refers to a sigmoid function that maps the output to [0, 1]. If we denote the ground truth binding as y, which is either 0 or 1, and denote all the parameters inside the network as W then the loss function for the SSnet model can be defined as binary cross entropy, which is computed as:
where M is the number of samples in the dataset. 
Grad-CAM method for heatmap generation
A neural network generally exhibits a large number of weights to be optimized so that complex information can be learned, however, some of this information could be irrelevant to a prediction task. For example, consider the task of identifying if a certain image contains a horse or not. If all horse images also contain a date information on the image and images without horse does not contains date information, the machine will quickly learn to detect the date rather than the goal object (a horse in this case). Therefore, it is essential to verify what a neural network considers "influential" for classification after training. Selvaraju et al. 31 proposed a Gradient-weighted Class Activation (Grad-CAM) based method
to generate a heatmap which shows important points in the feature data, based on a particular class of prediction. That is, this method uses activations inside the neural network to understand what portions of an image are most influential for a given classification. In the context of protein structures, this methods can help to elucidate which portions of the decomposition plot are most important for a given classification. These influential patterns in the decomposition plot can then be mapped to specific sub-structures in the protein.
Grad-CAM is computed by taking the gradient weight α k for all channels in a convolutional layer as
where k is the row in the final convolutional layer, Z is a normalization term, X (N ) is the activation of the final convolutional layer, andŷ is the final layer output. The heatmap S is then computed by the weighted sum of final layer activations:
This heatmap S specifies the important portions in the input sequence that are most responsible for a particular class activation. For each convolutional branch, we can apply this procedure to understand which portions of the input decomposition sequence are contributing the most, according to each filter size K = 5, 10, 15, 20. In this way, we can then map the most influential portions onto locations on the backbone of the protein. To the best of our knowledge, this procedure has never been applied to protein (or ligand) structures because
Grad-CAM has been rarely applied outside of image processing.
Evaluation criteria
The evaluation criteria for PLI in general is presented by the area under the receiver operating characteristics (AUC) 48 . The receiver operating characteristic curve is the plot of true positive rate vs false positive rate and the area under this curve is AUC. Thus AUC greater than 0.5 suggests that the model performs better than chance. However, AUC faces the early recognition problem (high positive rate for highest ranked ligands which are assayed first) and therefore, may incorrectly judge a model. Enrichment 
where N X% is the number of ligands in the top X% of the ranked ligands. EF thus considers an estimate on a random distribution for how many more actives can be found withing the early recognition threshold. BEDROC is interpreted as the probability that an active is ranked before a ligand taken from random probability distribution in an ordered list. An exponent factor α determines the shape of the distribution. In this work, we chose α = 20
following the bench-marking of fingerprints for ligand-based virtual screening 29 .
Datasets
The dataset used for the evaluation of PLI prediction models is of critical importance. The dataset should have credible positive and negative samples (i.e., protein-ligand pairs that interact and protein-ligand pairs that do not interact, respectively). However, most of the datasets applied currently for PLI prediction use randomly generated negative sample 51, 52 which creates noise in the data as there might be false negatives (i.e. a sample that is categorized as negative by the model but is positive).
The highly credible negative samples datasets human and C.elegans were created by Liu an experimental validation of SSnet is mandatory. We considered the BindingDB dataset 58 which is a public, web-accessible database of measured experimental binding affinities and contains around 1.3 million data records. We created a database by considering the following properties for each data entry 1. The target has PDB ID cross-referenced as 3D structure. The first annotated structure is taken as reference PDB file.
2. The ligand has SMILES representation in the entry.
3. Record has IC50 value (a measure of strength of binding) and is either less than 10 nM (positive) or greater than 10 µM (negative). 
Results and discussion
The model proposed in the present study, SSnet, takes as inputs the PDB format file (to extract curvature κ and torsion τ ) for targets and SMILES strings for ligands. The SMILES string is further converted into molecular descriptors utilizing the methods ECF 28 , Avalon 29 , GNN 27 , and CLP 25 respectively. DNNs with convolutional neural networks (CNN) have a large number of weights to optimize and therefore require a large number of data instances to be able to learn. However, in the human and C.elegans dataset the number of instances are insufficient, causing SSnet to overfit (shown as Figure 3 in the supporting information).
To overcome this problem, we ignored the convolution layer and directly fed the proteins' curvature and torsion to the fully connected dense layer (similarly to ligands processing) for human and C.elegans dataset. Avalon. CLP gives a descent AUC score of 0.966, however, it is the lowest performing model. CLP is based on autoencoder which is trained to take an input SMILES string, converts it to a lower dimension, and reproduces the SMILES string back. In this way CLP is able to generate a lower dimensional vector for a given SMILES string. However, relevant information required for the prediction of PLI might have lost from the ligands which explains its lower performance. ECF and Avalon have almost similar AUC score as they both directly provide the information of the atoms and functional groups a ligand contains. For further comparison on human and C.elegans datasets we considered Avalon as ligand descriptor. 53 .
In addition, we evaluated our model with the DUD-E dataset as shown in Figure 4 . The best performing molecular descriptor ECF was employed for ligands and branch convolution neural network was employed for proteins. The performance of other molecular descriptors are shown as Table 1 able to outperform all these models in terms of AUC with an AUC score of 0.984. These results suggest that the curvature and torsion information accumulates compact information for PLI prediction tasks. The learning curve of loss over epochs is shown as Figure 8a of the supporting information.
As described in the evaluation criteria section, accuracy and AUC are not the best metric for PLI prediction evaluation. The Receiver operating characteristics (ROC) curve on the DUD-E dataset for each single protein in the test set (30 proteins) is shown as Figure 4 in the supporting information. For validation, using an experimental dataset taken from BindingDB, we benchmarked GNN-CNN, which has outperformed not only partial information (sequence etc.) based model but 3D descriptor based models as well, to predict PLI. We retrained/tested GNN-CNN with the same train/test dataset used for SSnet. The hyperparameters for GNN-CNN are provided in section 2 of the supporting information. Figure 7 shows the average AUC, BEDROC and EF on the test set of BindingDB. Similar with AUC, SSnet outperforms GNN-CNN in all metric criteria. The box plot for SSnet and GNN-CNN is shown as Figure 9 and 10 respectively in the supporting information. The learning curve of loss over epochs is shown as Figure 8b of the supporting information.
Latent space for proteins
In order to start the unraveling of the inner workings of our model we analysed the outputs from the final layers in the global max pooling layer (GMP) (Protein concatenate layer in Figure 2 ) using the t-distributed Stochastic Neighbor Embedding (t-SNE). The t-SNE Embedding (t-SNE) of GMP is shown as Figure 7 Figure 8 : Grad-CAM visualization of the heatmap for nine different proteins. The heatmap is a rainbow mapping with violet as the lowest and red as the highest value. The ligand and other small molecules are shown in white. a) and b) shows that the heatmap generates high value for residues near the binding site. c) shows a protein with four active sites and the model detects them all. The model also detects places where small molecules interact apart from the active site. d) shows a protein's allosteric site which inhibits toxicity from drugs binding at the active site. e), f) and g) shows cryptic sites with the protein-ligand complex shown in white. The heatmap is shown only for the apo protein which is aligned with the protein-ligand complex. Similarly, h) and i) are also cryptic sites, however, in the allosteric location attention relative to the others. However, the information that is learned from a neural attention layer could be misinterpreted since it adds an additional layer, increasing the complexity of the network. To tackle this problem we opted for Grad-CAM, due to its capability to provide a better insight for which points in the feature are important to predict a particular class based on convolution outputs. A convolution layer is used as it contains most of the spatial information which is lost in a fully connected dense layer. Figure 8a and 8b show the heatmaps generated by Grad-CAM on a homo sapiens protein classified as hormone/growth factor 65 Another example can be found in a Plasmodium falciparum protein shown in Figure 8d (PDB ID -5IFU, not in the training set of DUD-E dataset) in complex with glyburide. It is important to note that glyburide does not bind to the known primary binding site of the protein but in a distinct secondary binding site. The interaction between glyburide and this secondary binding site causes the inhibition of the protein, making this ligand an allosteric inhibitor. It has been shown that the presence of glyburide overcomes the toxicity related to drugs binding at the active site of this protein 68 , which is one of the characteristics of an allosteric inhibitor. The fact that SSnet model is able to highlight the portion of the protein where glyburide could bind, which is not the known orthosteric binding site but an allosteric one, represents one of the various applications that can be carried out with this model. These results also suggest that the SSnet model is learning the relevant information and generalizing the data learned to predict PLI for both unknown proteins and ligands.
Applicability of SSnet
In this work, a ML/DL method that is excellent tools in recognizing patterns has been developed. As we mentioned in section 2, curvature and torsion form various patterns that a machine finds easier to recognize and includes intricate details such as turns, β sheets, α helixes and many more. These patterns are a consequence of the various interactions within a protein (such as side chain interactions). However, the involvement of a ligand perturbs the secondary structure and might cause a slight difference from the original unbound protein structure. To check if SSnet can discover drugs based on an unbound protein structure or a slightly different conformation of the protein, we focused on the following:
• Can SSnet predict the same results using an unbound protein structure or a different conformation of the same protein?
• Can SSnet detect cryptic sites based on unbound protein structures? Table 3 shows the results of prediction when different proteins conformations are utilized for 10 randomly selected targets in the test set of DUD-E dataset. The first and second columns denote the PDB ID for a protein ligand complex (PLC) in the DUD-E dataset and PDB ID of a different conformation (DC) of the same protein, respectively. The first five rows have DC with the same protein in PLC bound with a different ligand, and the remaining are apo proteins of the PLCs. The presence of a ligand changes the secondary structure of the protein and therefore we observe a range of root-mean-squared-distance (RMSD) from 0.175 to 0.666 between a PLC-DC pair. The prediction results for each PLC-DC pair in predicting actives and inactives are exactly the same. These results suggest that SSnet is able to predict similar results for a given protein regardless its specific conformation.
Some proteins have binding sites that are not easily detectable as a ligand could induce a significant conformation change. The cryptic proteins are one such example where a cryptic site is defined as a binding site that is present in a protein-ligand complex but not in the apo protein (unbound protein). 69 The change in conformation upon ligand binding is a dynamical phenomena and has been well-known in the literature. 70 Figure 8 (e-i) shows cryptic sites for 5 different proteins taken from CryptoSite set. 71 Figure 8e shows the bound (protein with heatmap) and unbound (grey) proteins (cAMP-dependent protein kinase known as Protein Kinase A) respectively. SSnet was utilized to predict the heatmap of unbound protein.
The unbound structure with PDB ID 2GFC has the activation loop that protrudes into the active site, closing the binding pocket. The bound structure with PDB-ID 2JDS resides in partially hydrophobic outer region of the active site. SSnet predicts from the unbound structure that the ligand will bind strongly to this protein and highlights location closer to the actual binding site. Retrieving such information is of critical importance as these sites are practically impossible to detect using classical virtual screening methods. Another example is provided by the protein Glutamate Racemase (GluR) shown in Figure 8f with PDB IDs 2OHV and 2OHG as bound and unbound pair, respectively. Similarly, Figure 8g shows the bound-unbound proteins for protease beta-secretase 1 (BACE-1) with PDB IDs 3IXJ-1W50, respectively, where the unbound structure has a low score of binding as the loop comprising residues 71-74 is away from the active site. In both cases SSnet was able to detect that a ligand would be active when tested on unbound protein despite significant differences in the protein structure. SSnet provided a high probability score of more than 0.98 in both scenarios and highlighted high importance regions near the binding site. Figure 8 (h-i) shows cryptic sites for bound-unbound pairs with PDB IDs 2BYS-3PEO (Nicotinic acetylcholine receptor) and 3F82-1R1W (Tyrosine kinase domain of C-MET) respectively. These are the allosteric sites. The allosteric communication is dynamic in nature and the allosteric modulators bind at flexible regions in the protein even without pre-formed binding sites. Allosteric sites are important for drug discovery 72, 73 and are a prime motivation when analysing cryptic sites.
SSnet being able to detect such sites based on apo protein suggests the versatile nature of the model and shines light on the potential future of fast drug screening models.
Conclusion
In this work we have approached the prediction of protein-ligand interaction based on the secondary structure of proteins and the molecular description of ligands. The protein's secondary structure is acknowledged as the curvature and torsion of the backbone of protein.
The curvature and torsion are comprised of 1D data and therefore has compact information that the machine finds easier to learn. In comparison of 3D or 2D feature representation for proteins, the information provided to the machine is sparse and therefore these models have poor performance. The curvature and torsion have unique patterns which are detected by convolution network added in the model. We showed that the machine learns important points in proteins, with the help of a convolution network, where it should look for predicting a protein-ligand interaction. The molecular descriptors were accessed based on several previous studies (graph neural network, variational auto encoder, morgan/circular fingerprints and Avalon fingerprints). Inspired by the t-SNE results for the last layer in protein embedding we propose a possible latent space for proteins that encodes important information about the protein bioactivity and further exploration would result in a metric to compare proteins based on their bioactivity. Our SSnet model outperforms previous models and it predicts protein-ligand interactions in the human, C.elegans,DUD-E, and BindingDB dataset. Our model also shows a strong potential in detecting active sites of proteins even for proteins with multiple binding sites. It also finds all possible locations including allosteric sites and cryptic sites where a ligand might interact, which is an important information for chemists to regulate various properties of proteins such as mitigating toxicity.
It is important to note that SSnet is an ML/DL based method and therefore, is much faster than traditional methods such as Vina 62 or Smina 63 . The SSnet model utilizes secondary structure information of the protein and, since it only processes CA atoms, it does not necessarily require high resolution structural information. The preliminary analysis done on bound-unbound proteins show that SSnet can predict similar results even with different conformations of the protein including cryptic sites. SSnet requires a single conformation (apo protein or protein-ligand complex) to predict whether a ligand is active or not even if the protein-ligand complex has different secondary structure. However, to derive general rules, a more rigorous testing would be required. Another important issue that needs to be addressed is to distinguish between better and lesser binders. Our study suggests that end-to-end learning models based on the secondary structure of proteins have great potential in bioinformatics which is not just confined to protein ligand prediction and can be extended to various biological studies such as protein-protein interaction, protein-DNA interaction, protein-RNA interactions etc. We leave these explorations of the SSnet model for future work.
